Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 3 April 2012
Vol. 5, Issue 218, p. pc7
[DOI: 10.1126/scisignal.2003040]

PODCASTS

Science Signaling Podcast: 3 April 2012

David M. Sabatini1,2,3,4, Joseph A. Baur5, and Annalisa M. VanHook6

1 Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA.
2 Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
3 The Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, MA 02142, USA.
4 The David H. Koch Center for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
5 Institute for Diabetes, Obesity, and Metabolism and Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
6 Web Editor, Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, NW, Washington, DC 20005, USA.

Abstract: This Podcast features a conversation with the authors of a Report published in the March 30th issue of Science Magazine. David Sabatini and Joseph Baur discuss how the drug rapamycin affects longevity and insulin sensitivity. Rapamycin is an immunosuppressant that is used to prevent transplant rejection. It can also extend the life span of many animals, but long-term rapamycin treatment impairs the sensitivity to insulin and leads to glucose intolerance. In a new collaborative study published in Science, Sabatini and Baur’s groups have dissected the mechanism of rapamycin action and found that its effects on life span and insulin sensitivity are mediated by different molecular targets. Their research also overturned the widely held belief that rapamycin only inhibits one of two related protein complexes.

Citation: D. M. Sabatini, J. A. Baur, A. M. VanHook, Science Signaling Podcast: 3 April 2012. Sci. Signal. 5, pc7 (2012).

Read the Full Text



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882